<DOC>
	<DOCNO>NCT02623088</DOCNO>
	<brief_summary>Obstructive sleep apnea syndrome responsible endothelial dysfunction , independent cardio-vascular risk factor . Assessment pulse wave velocity ( PWV ) peripheral arterial tone ( PAT ) study measurement arterial stiffness , strong predictor late cardiovascular event . This study compare long term evolution arterial stiffness ( PWV ) endothelial dysfunction ( PAT ) patient treat Positive Airway Pressure Therapies .</brief_summary>
	<brief_title>CPAP Effect Vascular Function Obstructive Sleep Apnea</brief_title>
	<detailed_description>Obstructive sleep apnea ( OSA ) syndrome responsible vascular damage . Intermittent hypoxia cause oxidative stress low-grade inflammation . By way increase sympathetic outflow , 's result endothelial dysfunction , atherosclerosis increase arterial stiffness . Finally mechanisms responsible cardiovascular comorbidities : hypertension , cardiac arrhythmia Left ventricular dysfunction . This patient present coronary disease Strokes . OSA characterize intermittent hypoxia , associate atherosclerosis vascular inflammation . Polymorphonuclear leukocyte ( PMNs ) implicate vascular inflammation produce oxidize radical proteolytic enzymes PMN-endothelium interaction . Reactive oxygen specie ( ROS ) production increase activated cell attachment , PMNs release additional ROS induce endothelial cell injury . Continuous positive airway pressure ( CPAP ) current `` gold standard '' treatment OSA , Use CPAP restore respiratory flow , prevent nocturnal respiratory event daytime symptom . Arterial stiffness endothelial dysfunction link obstructive sleep apnea severity dose-effect relationship . And meta-analyse show significant improvement indices arterial stiffness CPAP treatment patient OSA . Assessment pulse wave velocity peripheral arterial tone study measurement arterial stiffness . And strong predictor late cardiovascular event The investigator compare long term evolution arterial stiffness ( PWV ) endothelial dysfunction ( Peripheral arterial tone ) patient OSA treat Positive Airway Pressure Therapies .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>Any patient initial visit 47 year VNISOH protocol ( RÃ©f CPP SudEst V : 38/2006/2 ) Male female patient , age 2075 year initial visit 4 7 year ; Patients BMI &gt; 30kg / m2 diagnostic ; Patient affiliate social security ; Having give write consent participate study . Person private liberty judicial administrative decision , person legal protection measure ( pregnant nursing , patient guardianship ) Article L11218 Exclusion period study Patient die lose sight since initial visit 47 year</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Obstructive Sleep Apnea</keyword>
	<keyword>Endothelial dysfunction</keyword>
	<keyword>Arterial stiffness</keyword>
	<keyword>PAP therapy</keyword>
</DOC>